Diagnostic Criteria for Human Disharmony Loop. حسب James M. Friedman (22522150)

"…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …"

Patient Example. حسب James M. Friedman (22522150)

The Human Disharmony Loop Clinical Presentation. حسب James M. Friedman (22522150)

Pain and Function Outcomes Following PM Tenotomy. حسب James M. Friedman (22522150)

Ranking of factors in order of importance as reported by survey respondents regarding the difficulty in accessing the lower uterine segment (A), complicated fetal extraction in ces... حسب María Jesús Cancelo Hidalgo (12154030)

Changes in growth characteristics (A = shoot fresh weight; B = shoot dry weight; C = root fresh weight; D = root dry weight) of M. stenopetala under drought conditions.... حسب Nadia Khater (22553166)

Estimated coefficients from the SARIMA model of new COVID-19 deaths assuming a gradual effect following the implementation of two ETSs and one executive order in Oregon. حسب Raul Cruz-Cano (3751321)

Magnification X2 of Fig 4A. حسب Huan W. Yang (19746645)

"…There were no significant changes in NF-κB signalling between vaccine and Dkp23 infection in PK-15 cells, except for moderate levels of differences in NF-κB target genes expression which might be a reflection of differences in intracellular bacterial load. …"

The Laboratory Animal Flow Diagram. حسب Xueqin lu (22250795)

"…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …"

¹H NMR spectra for kylo-0603. حسب Xueqin lu (22250795)

"…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …"

¹³C NMR spectra for Kylo-0603. حسب Xueqin lu (22250795)

"…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …"

The structures of T3 and Kylo-0603. حسب Xueqin lu (22250795)

"…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …"

Synthesis process of Kylo-0603. حسب Xueqin lu (22250795)

"…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …"

ESI-HRMS spectra for Kylo-0603. حسب Xueqin lu (22250795)

"…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …"

Effects of Kylo-0603 on the expression of related genes of the MASH mouse models. حسب Xueqin lu (22250795)

General procedure for the synthesis of B. حسب Xueqin lu (22250795)

Effects of Kylo-0603 on body weight, organ weight, and body fat content. حسب Xueqin lu (22250795)

The body weight and cholesterol levels of the mice were recorded before the administration of the drug. حسب Xueqin lu (22250795)

The trends of cholesterol metabolism-related gene expression in liver tissue. حسب Xueqin lu (22250795)

Kylo-0603’s EC50 & tissue levels. حسب Xueqin lu (22250795)